Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies

Clinical trial NCT02433626 · UNKNOWN

Trial details

NCT number: NCT02433626
Sponsor: Critical Outcome Technologies Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer Fallopian Tube Cancer Endometrial Cancer Cervical Cancer Peritoneal Cancer Head and Neck Cancer HNSCC Colorectal Cancer Lung Cancer Pancreatic Cancer

Start date: 2015-12-01
Primary completion: 2019-12-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.